The La-related proteins, a family with connections to cancer

Biomolecules

Volumn 5, Issue 4, 2015, Pages 2701-2722

  Stavraka, Chara ^a   Blagden, Sarah ^a,b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Cancer; LARP; LARP1; mRNA; Proliferation; RBP; RNA binding; SS B; Transcription; Translation

Indexed keywords

CYCLIN D1; JANUS KINASE 2; LARP 1 PROTEIN; LARP 4A PROTEIN; LARP 4B PROTEIN; LARP 6 PROTEIN; LARP 7 PROTEIN; LARP PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN; MEMBRANE PROTEIN; PROTEIN P53; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; AUTOANTIGEN; RIBONUCLEOPROTEIN; SS-B ANTIGEN;

CARCINOGENESIS; CELL CYCLE PROGRESSION; EMBRYO DEVELOPMENT; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; INTERNAL RIBOSOME ENTRY SITE; NEOPLASM; NONHUMAN; OOCYTE DEVELOPMENT; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; REVIEW; SJOEGREN SYNDROME; SPERMATOGENESIS; SYSTEMIC LUPUS ERYTHEMATOSUS; UPREGULATION; ANIMAL; CHEMISTRY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MULTIGENE FAMILY;

ANIMALS; AUTOANTIGENS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MULTIGENE FAMILY; NEOPLASMS; RIBONUCLEOPROTEINS;

EID: 84959446749     PISSN: None     EISSN: 2218273X     Source Type: Journal    
DOI: 10.3390/biom5042701     Document Type: Review

References (115)

1. Stewart, B.W.; Wild, C.P. World Cancer Report; International Agency for Research on Cancer (IARC): Lyon, France, 2014.
2. Jemal, A.; Center, M.M.; DeSantis, C.; Ward, E.M. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol. Biomark. Prev. 2010, 19, 1893-1907.
3. Jiang, T.; Zhou, C. The past, present and future of immunotherapy against tumor. Transl. Lung Cancer Res. 2015, 4, 253-264.
4. Meyerson, M.; Gabriel, S.; Getz, G. Advances in understanding cancer genomes through secondgeneration sequencing. Nat. Rev. Genet. 2010, 11, 685-696.
5. Chin, L.; Andersen, J.N.; Futreal, P.A. Cancer genomics: From discovery science to personalized medicine. Nat. Med. 2011, 17, 297-303.
6. Bayraktar, S.; Gluck, S. Molecularly targeted therapies for metastatic triple-negative breast cancer. Breast Cancer Res. Treat. 2013, 138, 21-35.
7. Swain, S.M.; Baselga, J.; Kim, S.B.; Ro, J.; Semiglazov, V.; Campone, M.; Ciruelos, E.; Ferrero, J.M.; Schneeweiss, A.; Heeson, S.; et al. Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer. N. Engl. J. Med. 2015, 372, 724-734.
8. Michielin, O.; Hoeller, C. Gaining momentum: New options and opportunities for the treatment of advanced melanoma. Cancer Treat. Rev. 2015, 41, 660-670.
9. Minguet, J.; Smith, K.H.; Bramlage, C.P.; Bramlage, P. Targeted therapies for treatment of renal cell carcinoma: Recent advances and future perspectives. Cancer Chemother. Pharmacol. 2015, 76, 219-233.
10. Cancer Research UK. Available online: Http://www.Cancerresearchuk.Org/health-professional/ cancer-statistics/survival (accessed on 25 July 2015).
11. Kechavarzi, B.; Janga, S.C. Dissecting the expression landscape of RNA-binding proteins in human cancers. Genome Biol. 2014, 15, R14.
12. Parkin, D.M.; Boyd, L.; Walker, L.C. The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010. Br. J. Cancer 2011, 105, S77-S81.
13. Castello, A.; Fischer, B.; Eichelbaum, K.; Horos, R.; Beckmann, B.M.; Strein, C.; Davey, N.E.; Humphreys, D.T.; Preiss, T.; Steinmetz, L.M.; et al. Insights into RNA biology from an atlas of mammalian mRNA-binding proteins. Cell 2012, 149, 1393-1406.
14. Avdulov, S.; Li, S.; Michalek, V.; Burrichter, D.; Peterson, M.; Perlman, D.M.; Manivel, J.C.; Sonenberg, N.; Yee, D.; Bitterman, P.B.; et al. Activation of translation complex eIF4F is essential for the genesis and maintenance of the malignant phenotype in human mammary epithelial cells. Cancer Cell 2004, 5, 553-563.
15. Wendel, H.G.; Silva, R.L.; Malina, A.; Mills, J.R.; Zhu, H.; Ueda, T.; Watanabe-Fukunaga, R.; Fukunaga, R.; Teruya-Feldstein, J.; Pelletier, J.; et al. Dissecting eIF4E action in tumorigenesis. Genes Dev. 2007, 21, 3232-3237.
16. Lee, H.W.; Lee, E.H.; Lee, J.H.; Kim, J.E.; Kim, S.H.; Kim, T.G.; Hwang, S.W.; Kang, K.W. Prognostic significance of phosphorylated 4E-binding protein 1 in non-small cell lung cancer. Int. J. Clin. Exp. Pathol. 2015, 8, 3955-3962.
17. Graff, J.R.; Konicek, B.W.; Lynch, R.L.; Dumstorf, C.A.; Dowless, M.S.; McNulty, A.M.; Parsons, S.H.; Brail, L.H.; Colligan, B.M.; Koop, J.W.; et al. eIF4E activation is commonly elevated in advanced human prostate cancers and significantly related to reduced patient survival. Cancer Res. 2009, 69, 3866-3873.
18. Assouline, S.; Culjkovic, B.; Cocolakis, E.; Rousseau, C.; Beslu, N.; Amri, A.; Caplan, S.; Leber, B.; Roy, D.C.; Miller, W.H., Jr.; et al. Molecular targeting of the oncogene eIF4E in acute myeloid leukemia (AML): A proof-of-principle clinical trial with ribavirin. Blood 2009, 114, 257-260.
19. Bousquet-Antonelli, C.; Deragon, J.M. A comprehensive analysis of the La-motif protein superfamily. RNA 2009, 15, 750-764.
20. Bayfield, M.A.; Yang, R.; Maraia, R.J. Conserved and divergent features of the structure and function of La and La-related proteins (LARPs). Biochim. Biophys. Acta 2010, 1799, 365-378.
21. Ponting, C.P.; Mott, R.; Bork, P.; Copley, R.R. Novel protein domains and repeats in drosophila melanogaster: Insights into structure, function, and evolution. Genome Res. 2001, 11, 1996-2008.
22. Marchler-Bauer, A.; Derbyshire, M.K.; Gonzales, N.R.; Lu, S.; Chitsaz, F.; Geer, L.Y.; Geer, R.C.; He, J.; Gwadz, M.; Hurwitz, D.I.; et al. CDD: NCBI's conserved domain database. Nucleic Acids Res. 2015, 43, D222-D226.
23. Yang, R.; Gaidamakov, S.A.; Xie, J.; Lee, J.; Martino, L.; Kozlov, G.; Crawford, A.K.; Russo, A.N.; Conte, M.R.; Gehring, K.; et al. La-related protein 4 binds poly(A), interacts with the poly(A)-binding protein MLLE domain via a variant PAM2w motif, and can promote mRNA stability. Mol. Cell. Biol. 2011, 31, 542-556.
24. Genecards. Available online: Http://www.Genecards.Org (accessed on 20 July 2015).
25. Alspaugh, M.A.; Talal, N.; Tan, E.M. Differentiation and characterization of autoantibodies and their antigens in Sjögren's syndrome. Arthritis Rheum. 1976, 19, 216-222.
26. Chauvet, S.; Maurel-Zaffran, C.; Miassod, R.; Jullien, N.; Pradel, J.; Aragnol, D. DLARP, a new candidate Hox target in Drosophila whose orthologue in mouse is expressed at sites of epithelium/ mesenchymal interactions. Dev. Dyn. 2000, 218, 401-413.
27. Wolin, S.L.; Cedervall, T. The La protein. Ann. Rev. Biochem. 2002, 71, 375-403.
28. Angenstein, F.; Evans, A.M.; Settlage, R.E.; Moran, S.T.; Ling, S.C.; Klintsova, A.Y.; Shabanowitz, J.; Hunt, D.F.; Greenough, W.T. A receptor for activated C kinase is part of messenger ribonucleoprotein complexes associated with polyA-mRNAs in neurons. J. Neurosci. 2002, 22, 8827-8837.
29. Valavanis, C.; Wang, Z.; Sun, D.; Vaine, M.; Schwartz, L.M. Acheron, a novel member of the lupus antigen family, is induced during the programmed cell death of skeletal muscles in the moth manduca sexta. Gene 2007, 393, 101-109.
30. Krueger, B.J.; Jeronimo, C.; Roy, B.B.; Bouchard, A.; Barrandon, C.; Byers, S.A.; Searcey, C.E.; Cooper, J.J.; Bensaude, O.; Cohen, E.A.; et al. LARP7 is a stable component of the 7SK snRNP while P-TEFb, HEXIM1 and hnRNP A1 are reversibly associated. Nucleic Acids Res. 2008, 36, 2219-2229.
31. Yoo, C.J.; Wolin, S.L. The yeast La protein is required for the 3' endonucleolytic cleavage that matures tRNA precursors. Cell 1997, 89, 393-402.
32. Copela, L.A.; Chakshusmathi, G.; Sherrer, R.L.; Wolin, S.L. The La protein functions redundantly with tRNA modification enzymes to ensure tRNA structural stability. RNA 2006, 12, 644-654.
33. Blackstock, C.D.; Higashi, Y.; Sukhanov, S.; Shai, S.Y.; Stefanovic, B.; Tabony, A.M.; Yoshida, T.; Delafontaine, P. Insulin-like growth factor-1 increases synthesis of collagen type I via induction of the mRNA-binding protein LARP6 expression and binding to the 5' stem-loop of COL1a1 and COL1a2 mRNA. J. Biol. Chem. 2014, 289, 7264-7274.
34. Wang, H.; Stefanovic, B. Role of LARP6 and nonmuscle myosin in partitioning of collagen mRNAs to the ER membrane. PLoS ONE 2014, 9, e108870.
35. Markert, A.; Grimm, M.; Martinez, J.; Wiesner, J.; Meyerhans, A.; Meyuhas, O.; Sickmann, A.; Fischer, U. The La-related protein LARP7 is a component of the 7SK ribonucleoprotein and affects transcription of cellular and viral polymerase II genes. EMBO Rep. 2008, 9, 569-575.
36. Petz, M.; Them, N.; Huber, H.; Beug, H.; Mikulits, W. La enhances IRES-mediated translation of laminin B1 during malignant epithelial to mesenchymal transition. Nucleic Acids Res. 2012, 40, 290-302.
37. Tcherkezian, J.; Cargnello, M.; Romeo, Y.; Huttlin, E.L.; Lavoie, G.; Gygi, S.P.; Roux, P.P. Proteomic analysis of cap-dependent translation identifies LARP1 as a key regulator of 5'TOP mRNA translation. Genes Dev. 2014, 28, 357-371.
38. Fonseca, B.D.; Zakaria, C.; Jia, J.J.; Graber, T.E.; Svitkin, Y.; Tahmasebi, S.; Healy, D.; Hoang, H.D.; Jensen, J.M.; Diao, I.T.; et al. La-related protein 1 (LARP1) represses terminal oligopyrimidine (TOP) mRNA translation downstream of mtor complex 1 (mTORC1). J. Biol. Chem. 2015, 290, 15996-16020.
39. Schaffler, K.; Schulz, K.; Hirmer, A.; Wiesner, J.; Grimm, M.; Sickmann, A.; Fischer, U. A stimulatory role for the La-related protein 4B in translation. RNA 2010, 16, 1488-1499.
40. Cai, L.; Fritz, D.; Stefanovic, L.; Stefanovic, B. Binding of LARP6 to the conserved 5' stem-loop regulates translation of mRNAs encoding type I collagen. J. Mol. Biol. 2010, 395, 309-326.
41. Sommer, G.; Dittmann, J.; Kuehnert, J.; Reumann, K.; Schwartz, P.E.; Will, H.; Coulter, B.L.; Smith, M.T.; Heise, T. The RNA-binding protein La contributes to cell proliferation and CCND1 expression. Oncogene 2011, 30, 434-444.
42. Trotta, R.; Vignudelli, T.; Candini, O.; Intine, R.V.; Pecorari, L.; Guerzoni, C.; Santilli, G.; Byrom, M.W.; Goldoni, S.; Ford, L.P.; et al. BCR/ABL activates MDM2 mRNA translation via the La antigen. Cancer Cell 2003, 3, 145-160.
43. Mura, M.; Hopkins, T.G.; Michael, T.; Abd-Latip, N.; Weir, J.; Aboagye, E.; Mauri, F.; Jameson, C.; Sturge, J.; Gabra, H.; et al. LARP1 post-transcriptionally regulates mTOR and contributes to cancer progression. Oncogene 2015, 34, 5025-5036.
44. Burrows, C.; Abd Latip, N.; Lam, S.J.; Carpenter, L.; Sawicka, K.; Tzolovsky, G.; Gabra, H.; Bushell, M.; Glover, D.M.; Willis, A.E.; et al. The RNA binding protein LARP1 regulates cell division, apoptosis and cell migration. Nucleic Acids Res. 2010, 38, 5542-5553.
45. Aoki, K.; Adachi, S.; Homoto, M.; Kusano, H.; Koike, K.; Natsume, T. LARP1 specifically recognizes the 3' terminus of poly(A) mRNA. FEBS Lett. 2013, 587, 2173-2178.
46. Blagden, S.P.; Gatt, M.K.; Archambault, V.; Lada, K.; Ichihara, K.; Lilley, K.S.; Inoue, Y.H.; Glover, D.M. Drosophila LARP associates with poly(A)-binding protein and is required for male fertility and syncytial embryo development. Dev. Biol. 2009, 334, 186-197.
47. Weng, H.; Kim, C.; Valavanis, C.; Wang, Z.; Schwartz, L.M. Acheron, an novel La antigen family member, binds to cask and forms a complex with ID transcription factors. Cell. Mol. Biol. Lett. 2009, 14, 273-287.
48. Muniz, L.; Egloff, S.; Kiss, T. RNA elements directing in vivo assembly of the 7SK/MePCE/LARP7 transcriptional regulatory snRNP. Nucleic Acids Res. 2013, 41, 4686-4698.
49. Alfano, C.; Sanfelice, D.; Babon, J.; Kelly, G.; Jacks, A.; Curry, S.; Conte, M.R. Structural analysis of cooperative RNA binding by the La motif and central RRM domain of human La protein. Nat. Struct. Mol. Biol. 2004, 11, 323-329.
50. Maraia, R.J.; Bayfield, M.A. The La protein-RNA complex surfaces. Mol. Cell 2006, 21, 149-152.
51. Dong, G.; Chakshusmathi, G.; Wolin, S.L.; Reinisch, K.M. Structure of the La motif: A winged helix domain mediates RNA binding via a conserved aromatic patch. EMBO J. 2004, 23, 1000-1007.
52. Lahr, R.M.; Mack, S.M.; Heroux, A.; Blagden, S.P.; Bousquet-Antonelli, C.; Deragon, J.M.; Berman, A.J. The La-related protein 1-specific domain repurposes HEAT-like repeats to directly bind a 5'TOP sequence. Nucleic Acids Res. 2015, 43, 8077-8088.
53. Singh, M.; Wang, Z.; Koo, B.K.; Patel, A.; Cascio, D.; Collins, K.; Feigon, J. Structural basis for telomerase RNA recognition and RNP assembly by the holoenzyme La family protein p65. Mol. Cell 2012, 47, 16-26.
54. Sommer, G.; Rossa, C.; Chi, A.C.; Neville, B.W.; Heise, T. Implication of RNA-binding protein La in proliferation, migration and invasion of lymph node-metastasized hypopharyngeal SCC cells. PLoS ONE 2011, 6, e25402.
55. Nakatake, M.; Monte-Mor, B.; Debili, N.; Casadevall, N.; Ribrag, V.; Solary, E.; Vainchenker, W.; Plo, I. JAK2(V617F) negatively regulates p53 stabilization by enhancing MDM2 via La expression in myeloproliferative neoplasms. Oncogene 2012, 31, 1323-1333.
56. Xie, C.; Huang, L.; Xie, S.; Xie, D.; Zhang, G.; Wang, P.; Peng, L.; Gao, Z. LARP1 predict the prognosis for early-stage and AFP-normal hepatocellular carcinoma. J. Transl. Med. 2013, doi:10.1186/1479-5876-11-272.
57. Kato, M.; Goto, Y.; Matsushita, R.; Kurozumi, A.; Fukumoto, I.; Nishikawa, R.; Sakamoto, S.; Enokida, H.; Nakagawa, M.; Ichikawa, T.; et al. MicroRNA-26a/b directly regulate La-related protein 1 and inhibit cancer cell invasion in prostate cancer. Int. J. Oncol. 2015, 47, 710-718.
58. Bai, S.W.; Herrera-Abreu, M.T.; Rohn, J.L.; Racine, V.; Tajadura, V.; Suryavanshi, N.; Bechtel, S.; Wiemann, S.; Baum, B.; Ridley, A.J. Identification and characterization of a set of conserved and new regulators of cytoskeletal organization, cell morphology and migration. BMC Biol. 2011, doi:10.1186/1741-7007-9-54.
59. Zhang, Y.; Peng, L.; Hu, T.; Wan, Y.; Ren, Y.; Zhang, J.; Wang, X.; Zhou, Y.; Yuan, W.; Wang, Q.; et al. La-related protein 4B maintains murine MLL-AF9 leukemia stem cell self-renewal by regulating cell cycle progression. Exp. Hematol. 2015, 43, 309-318.
60. Shao, R.; Scully, S.J., Jr.; Yan, W.; Bentley, B.; Mueller, J.; Brown, C.; Bigelow, C.; Schwartz, L.M. The novel lupus antigen related protein acheron enhances the development of human breast cancer. Int. J. Cancer. 2012, 130, 544-554.
61. He, N.; Jahchan, N.S.; Hong, E.; Li, Q.; Bayfield, M.A.; Maraia, R.J.; Luo, K.; Zhou, Q. A La-related protein modulates 7SK snRNP integrity to suppress P-TEFb-dependent transcriptional elongation and tumorigenesis. Mol. Cell 2008, 29, 588-599.
62. Ji, X.; Lu, H.; Zhou, Q.; Luo, K. LARP7 suppresses P-TEFb activity to inhibit breast cancer progression and metastasis. eLife 2014, 3, e02907.
63. Cheng, Y.; Jin, Z.; Agarwal, R.; Ma, K.; Yang, J.; Ibrahim, S.; Olaru, A.V.; David, S.; Ashktorab, H.; Smoot, D.T.; et al. LARP7 is a potential tumor suppressor gene in gastric cancer. Lab. Invest. 2012, 92, 1013-1019.
64. Stefanovic, B.; Stefanovic, L. Screening for antifibrotic compounds using high throughput system based on fluorescence polarization. Biology 2014, 3, 281-294.
65. Provost, T.T.; Reichlin, M. Antinuclear antibody-negative systemic lupus erythematosus. I. Anti-Ro(SSA) and anti-La(SSB) antibodies. J. Am. Acad. Dermatol. 1981, 4, 84-89.
66. Harley, J.B.; Alexander, E.L.; Bias, W.B.; Fox, O.F.; Provost, T.T.; Reichlin, M.; Yamagata, H.; Arnett, F.C. Anti-Ro (SS-A) and anti-La (SS-B) in patients with Sjögren's syndrome. Arthritis Rheum. 1986, 29, 196-206.
67. Franceschini, F.; Cavazzana, I. Anti-Ro/SSA and La/SSB antibodies. Autoimmunity 2005, 38, 55-63.
68. Intine, R.V.; Dundr, M.; Vassilev, A.; Schwartz, E.; Zhao, Y.; Zhao, Y.; Depamphilis, M.L.; Maraia, R.J. Nonphosphorylated human La antigen interacts with nucleolin at nucleolar sites involved in rRNA biogenesis. Mol. Cell. Biol. 2004, 24, 10894-10904.
69. Bhattacharya, R.; Perumal, K.; Sinha, K.; Maraia, R.; Reddy, R. Methylphosphate CAP structure in small RNAs reduces the affinity of RNAs to La protein. Gene Expr. 2002, 10, 243-253.
70. Bayfield, M.A.; Maraia, R.J. Precursor-product discrimination by La protein during tRNA metabolism. Nat. Struct. Mol. Biol. 2009, 16, 430-437.
71. Naeeni, A.R.; Conte, M.R.; Bayfield, M.A. RNA chaperone activity of human La protein is mediated by variant RNA recognition motif. J. Biol. Chem. 2012, 287, 5472-5482.
72. Liang, C.; Xiong, K.; Szulwach, K.E.; Zhang, Y.; Wang, Z.; Peng, J.; Fu, M.; Jin, P.; Suzuki, H.I.; Liu, Q. Sjogren syndrome antigen B (SSB)/La promotes global microrna expression by binding microRNA precursors through stem-loop recognition. J. Biol. Chem. 2013, 288, 723-736.
73. Martino, L.; Pennell, S.; Kelly, G.; Bui, T.T.; Kotik-Kogan, O.; Smerdon, S.J.; Drake, A.F.; Curry, S.; Conte, M.R. Analysis of the interaction with the hepatitis C virus mRNA reveals an alternative mode of RNA recognition by the human La protein. Nucleic Acids Res. 2012, 40, 1381-1394.
74. Kuehnert, J.; Sommer, G.; Zierk, A.W.; Fedarovich, A.; Brock, A.; Fedarovich, D.; Heise, T. Novel RNA chaperone domain of RNA-binding protein La is regulated by AKT phosphorylation. Nucleic Acids Res. 2015, 43, 581-594.
75. Holcik, M.; Korneluk, R.G. Functional characterization of the X-linked inhibitor of apoptosis (XIAP) internal ribosome entry site element: Role of La autoantigen in XIAP translation. Mol. Cell. Biol. 2000, 20, 4648-4657.
76. Kim, Y.K.; Back, S.H.; Rho, J.; Lee, S.H.; Jang, S.K. La autoantigen enhances translation of BIP mRNA. Nucleic Acids Res. 2001, 29, 5009-5016.
77. Meyuhas, O.; Kahan, T. The race to decipher the top secrets of top mRNAs. Biochim. Biophys. Acta 2015, 1849, 801-811.
78. Cardinali, B.; Carissimi, C.; Gravina, P.; Pierandrei-Amaldi, P. La protein is associated with terminal oligopyrimidine mRNAs in actively translating polysomes. J. Biol. Chem. 2003, 278, 35145-35151.
79. Crosio, C.; Boyl, P.P.; Loreni, F.; Pierandrei-Amaldi, P.; Amaldi, F. La protein has a positive effect on the translation of top mRNAs in vivo. Nucleic Acids Res. 2000, 28, 2927-2934.
80. Pellizzoni, L.; Cardinali, B.; Lin-Marq, N.; Mercanti, D.; Pierandrei-Amaldi, P. A xenopus laevis homologue of the La autoantigen binds the pyrimidine tract of the 5' UTR of ribosomal protein mrnas in vitro: Implication of a protein factor in complex formation. J. Mol. Biol. 1996, 259, 904-915.
81. Zhu, J.; Hayakawa, A.; Kakegawa, T.; Kaspar, R.L. Binding of the La autoantigen to the 5' untranslated region of a chimeric human translation elongation factor 1A reporter mRNA inhibits translation in vitro. Biochim. Biophys. Acta 2001, 1521, 19-29.
82. Schwartz, E.I.; Intine, R.V.; Maraia, R.J. Ck2 is responsible for phosphorylation of human La protein serine-366 and can modulate rpL37 5'-terminal oligopyrimidine mRNA metabolism. Mol. Cell. Biol. 2004, 24, 9580-9591.
83. Van Niekerk, E.A.; Willis, D.E.; Chang, J.H.; Reumann, K.; Heise, T.; Twiss, J.L. Sumoylation in axons triggers retrograde transport of the RNA-binding protein La. Proc. Natl. Acad. Sci. USA 2007, 104, 12913-12918.
84. Broekhuis, C.H.; Neubauer, G.; van der Heijden, A.; Mann, M.; Proud, C.G.; van Venrooij, W.J.; Pruijn, G.J. Detailed analysis of the phosphorylation of the human La (SS-B) autoantigen. (de)phosphorylation does not affect its subcellular distribution. Biochemistry 2000, 39, 3023-3033.
85. Brenet, F.; Socci, N.D.; Sonenberg, N.; Holland, E.C. AKT phosphorylation of La regulates specific mRNA translation in glial progenitors. Oncogene 2009, 28, 128-139.
86. Viedma-Rodriguez, R.; Baiza-Gutman, L.A.; Garcia-Carranca, A.; Moreno-Fierros, L.; Salamanca-Gomez, F.; Arenas-Aranda, D. Suppression of the death gene bik is a critical factor for resistance to tamoxifen in MCF-7 breast cancer cells. Int. J. Oncol. 2013, 43, 1777-1786.
87. Mendoza, M.; Mandani, G.; Momand, J. The MDM2 gene family. Biomol. Concepts 2014, 5, 9-19.
88. Pestell, R.G. New roles of cyclin D1. Am. J. Pathol. 2013, 183, 3-9.
89. Ichihara, K.; Shimizu, H.; Taguchi, O.; Yamaguchi, M.; Inoue, Y.H. A drosophila orthologue of LARP protein family is required for multiple processes in male meiosis. Cell Struct. Funct. 2007, 32, 89-100.
90. Karlas, A.; Machuy, N.; Shin, Y.; Pleissner, K.P.; Artarini, A.; Heuer, D.; Becker, D.; Khalil, H.; Ogilvie, L.A.; Hess, S.; et al. Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication. Nature 2010, 463, 818-822.
91. Engeland, C.E.; Oberwinkler, H.; Schumann, M.; Krause, E.; Muller, G.A.; Krausslich, H.G. The cellular protein lyric interacts with HIV-1 gag. J. Virol. 2011, 85, 13322-13332.
92. Gorgoni, B.; Gray, N.K. The roles of cytoplasmic poly(A)-binding proteins in regulating gene expression: A developmental perspective. Brief. Funct. Genomics Proteomics 2004, 3, 125-141.
93. Meyuhas, O.; Dreazen, A. Ribosomal protein S6 kinase from top mRNAs to cell size. Progress Mol. Biol. Transl. Sci. 2009, 90, 109-153.
94. Alexander, A.; Cai, S.L.; Kim, J.; Nanez, A.; Sahin, M.; MacLean, K.H.; Inoki, K.; Guan, K.L.; Shen, J.; Person, M.D.; et al. ATM signals to TSC2 in the cytoplasm to regulate mTORC1 in response to ROS. Proc. Natl. Acad. Sci. USA 2010, 107, 4153-4158.
95. Meyuhas, O.; Hornstein, E. Translational control of top mRNAs. In Translational Control of Gene Expression; Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY, USA, 2000; pp. 671-693.
96. Fraser, C.S.; Pain, V.M.; Morley, S.J. The association of initiation factor 4F with poly(A)-binding protein is enhanced in serum-stimulated xenopus kidney cells. J. Biol. Chem. 1999, 274, 196-204.
97. Rhodes, D.R.; Yu, J.; Shanker, K.; Deshpande, N.; Varambally, R.; Ghosh, D.; Barrette, T.; Pandey, A.; Chinnaiyan, A.M. Oncomine: A cancer microarray database and integrated data-mining platform. Neoplasia 2004, 6, 1-6.
98. Eswaran, J.; Horvath, A.; Godbole, S.; Reddy, S.D.; Mudvari, P.; Ohshiro, K.; Cyanam, D.; Nair, S.; Fuqua, S.A.; Polyak, K.; et al. RNA sequencing of cancer reveals novel splicing alterations. Sci. Rep. 2013, doi:10.1038/srep01689.
99. Merret, R.; Martino, L.; Bousquet-Antonelli, C.; Fneich, S.; Descombin, J.; Billey, E.; Conte, M.R.; Deragon, J.M. The association of a La module with the PABP-interacting motif PAM2 is a recurrent evolutionary process that led to the neofunctionalization of La-related proteins. RNA 2013, 19, 36-50.
100. Glenn, H.L.; Wang, Z.; Schwartz, L.M. Acheron, a lupus antigen family member, regulates integrin expression, adhesion, and motility in differentiating myoblasts. Am. J. Physiol. Cell Physiol. 2010, 298, C46-C55.
101. Song, M.H.; Aravind, L.; Muller-Reichert, T.; O'Connell, K.F. The conserved protein SZY-20 opposes the PLK4-related kinase ZYG-1 to limit centrosome size. Dev. Cell 2008, 15, 901-912.
102. Martino, L.; Pennell, S.; Kelly, G.; Busi, B.; Brown, P.; Atkinson, R.A.; Salisbury, N.J.; Ooi, Z.H.; See, K.W.; Smerdon, S.J.; et al. Synergic interplay of the La motif, RRM1 and the interdomain linker of LARP6 in the recognition of collagen mRNA expands the RNA binding repertoire of the La module. Nucleic Acids Res. 2015, 43, 645-660.
103. Weigand, J.E.; Boeckel, J.N.; Gellert, P.; Dimmeler, S. Hypoxia-induced alternative splicing in endothelial cells. PLoS ONE 2012, 7, e42697.
104. Diribarne, G.; Bensaude, O. 7SK RNA, a non-coding RNA regulating P-TEFb, a general transcription factor. RNA Biol. 2009, 6, 122-128.
105. Uchikawa, E.; Natchiar, K.S.; Han, X.; Proux, F.; Roblin, P.; Zhang, E.; Durand, A.; Klaholz, B.P.; Dock-Bregeon, A.C. Structural insight into the mechanism of stabilization of the 7SK small nuclear RNA by LARP7. Nucleic Acids Res. 2015, 43, 3373-3388.
106. Barboric, M.; Lenasi, T.; Chen, H.; Johansen, E.B.; Guo, S.; Peterlin, B.M. 7SK snRNP/P-TEFb couples transcription elongation with alternative splicing and is essential for vertebrate development. Proc. Natl. Acad. Sci. USA 2009, 106, 7798-7803.
107. Jang, M.K.; Mochizuki, K.; Zhou, M.; Jeong, H.S.; Brady, J.N.; Ozato, K. The bromodomain protein BRD4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription. Mol. Cell 2005, 19, 523-534.
108. Mori, Y.; Sato, F.; Selaru, F.M.; Olaru, A.; Perry, K.; Kimos, M.C.; Tamura, G.; Matsubara, N.; Wang, S.; Xu, Y.; et al. Instabilotyping reveals unique mutational spectra in microsatellite-unstable gastric cancers. Cancer Res. 2002, 62, 3641-3645.
109. Merret, R.; Descombin, J.; Juan, Y.T.; Favory, J.J.; Carpentier, M.C.; Chaparro, C.; Charng, Y.Y.; Deragon, J.M.; Bousquet-Antonelli, C. XRN4 and LARP1 are required for a HEAT-triggered mRNA decay pathway involved in plant acclimation and survival during thermal stress. Cell Rep. 2013, 5, 1279-1293.
110. Nykamp, K.; Lee, M.H.; Kimble, J.C. Elegans La-related protein, LARP-1, localizes to germline P bodies and attenuates RAS-MAPK signaling during oogenesis. RNA 2008, 14, 1378-1389.
111. Ciafre, S.A.; Galardi, S. MicroRNAs and RNA-binding proteins: A complex network of interactions and reciprocal regulations in cancer. RNA Biol. 2013, 10, 935-942.
112. Willems, L.; Tamburini, J.; Chapuis, N.; Lacombe, C.; Mayeux, P.; Bouscary, D. PI3K and mTOR signaling pathways in cancer: New data on targeted therapies. Curr. Oncol. Rep. 2012, 14, 129-138.
113. Wander, S.A.; Hennessy, B.T.; Slingerland, J.M. Next-generation mTOR inhibitors in clinical oncology: How pathway complexity informs therapeutic strategy. J. Clin. Investig. 2011, 121, 1231-1241.
114. Pallet, N.; Legendre, C. Adverse events associated with mTOR inhibitors. Expert Opin. Drug Saf. 2013, 12, 177-186.
115. Jorda, R.; Paruch, K.; Krystof, V. Cyclin-dependent kinase inhibitors inspired by roscovitine: Purine bioisosteres. Curr. Pharm. Des. 2012, 18, 2974-2980.